US considers rules preserving most pharma licensing deals with China
Sources say the US is working on rules for pharmaceutical investment in China that would likely preserve companies’ ability to strike most licensing deals for Chinese drugs.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.